NCT00131027 arm group 9d5ed678fe57bcca610140957afab571 [clinicaltrials_resource:NCT00131027/arm-group/9d5ed678fe57bcca610140957afab571]
Cytarabine [clinicaltrials_resource:2108b168dbfc118fd2fa1fe21cef8bf2]Prednisolone [clinicaltrials_resource:2477bd703ab2d4df5e2e3b0d984a5038]Dexamethasone [clinicaltrials_resource:45466834425f4f18017d9d259a66d880]Mercaptopurine [clinicaltrials_resource:512bd08f756af2e21e3cf7c5f635e32b]Daunorubicin [clinicaltrials_resource:5fd4e9a34095a2f8b17cc10c3dc9176e]L-asparaginase [clinicaltrials_resource:92c6fce3e1041c88c11d1547155e2d14]Doxorubicin [clinicaltrials_resource:99e8afedf58d7c75da6affc0e96e7779]Etoposide [clinicaltrials_resource:b54311eceb5c89559aebb3ce8447a014]Cyclophosphamide [clinicaltrials_resource:c5664f2321264ed0dafd67b70235c140]Methotrexate [clinicaltrials_resource:d5a8d792e160920393fd53919bf76375]Vincristine [clinicaltrials_resource:ebab01594522c3b696e84a9f552b6aaa]High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL) [clinicaltrials:NCT00131027]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00131027 arm group 9d5ed678fe57bcca610140957afab571 [clinicaltrials_resource:NCT00131027/arm-group/9d5ed678fe57bcca610140957afab571]
Bio2RDF identifier
NCT00131027/arm-group/9d5ed678fe57bcca610140957afab571
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 5ed678fe57bcca610140957afab571
description [clinicaltrials_vocabulary:description]
identifier
clinicaltrials_resource:NCT00131027/arm-group/9d5ed678fe57bcca610140957afab571
title
NCT00131027 arm group 9d5ed678fe57bcca610140957afab571
@en
type
label
NCT00131027 arm group 9d5ed678 ...... ed678fe57bcca610140957afab571]
@en